Data integrity guideline
Data Integrity and Compliance. With Drug CGMP. Questions and Answers. Guidance for Industry. Additional copies are available from:. , ,The purpose of this guidance is to clarify the role of data integrity in current good manufacturing practice (CGMP) for drugs, as required in 21 CFR parts ... ,Following are the highlights of the guidance document. 1. Data must be evaluated by the quality department. Invalid data must be recorded with supporting data. ,2021年7月1日 — PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI 041-1. 1 July 2021. PIC/S GUIDANCE. GOOD PRACTICES FOR DATA. MANAGEMENT AND INTEGRITY IN. ,Working document QAS/19.819. October 2019. Draft for comments. 1. GUIDELINE ON DATA INTEGRITY. 2. (October 2019). 3. DRAFT FOR COMMENTS. ,2020年6月1日 — Guideline on data integrity. 5. 6. 7. 8. Please send your comments to Dr Sabine Kopp, Team Lead, Norms and Standards for Pharmaceuticals,.
| 相關軟體 WinTools.net Professional 資訊 | |
|---|---|
 Data integrity guideline 相關參考資料
Data Integrity - US Food and Drug Administration
Data Integrity and Compliance. With Drug CGMP. Questions and Answers. Guidance for Industry. Additional copies are available from:. https://www.fda.gov Data Integrity and Compliance With CGMP Guidance for Industry
https://www.fda.gov FDA Guidance for Industry: Data Integrity and Compliance ...
The purpose of this guidance is to clarify the role of data integrity in current good manufacturing practice (CGMP) for drugs, as required in 21 CFR parts ... https://www.gmp-compliance.org FDA New Data Integrity Guidelines: Highlights ...
Following are the highlights of the guidance document. 1. Data must be evaluated by the quality department. Invalid data must be recorded with supporting data. https://www.pharmaguideline.co Guidance on Data Integrity - PICS
2021年7月1日 — PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI 041-1. 1 July 2021. PIC/S GUIDANCE. GOOD PRACTICES FOR DATA. MANAGEMENT AND INTEGRITY IN. https://picscheme.org GUIDELINE ON DATA INTEGRITY - WHO | World Health ...
Working document QAS/19.819. October 2019. Draft for comments. 1. GUIDELINE ON DATA INTEGRITY. 2. (October 2019). 3. DRAFT FOR COMMENTS. https://www.who.int Guideline on data integrity - WHO | World Health Organization
2020年6月1日 — Guideline on data integrity. 5. 6. 7. 8. Please send your comments to Dr Sabine Kopp, Team Lead, Norms and Standards for Pharmaceuticals,. https://cdn.who.int |